Alcohol Use in Sub-Saharan Africa
Attributable deaths from alcohol use across 48 countries in Sub-Saharan Africa.
View all Sub-Saharan Africa| # | Country | Attributable Deaths |
|---|
Alcohol Use is a modifiable risk factor tracked by the IHME Global Burden of Disease Study. The attributable deaths shown here represent the estimated number of deaths in Sub-Saharan Africa that could be prevented if exposure to this risk factor were eliminated or reduced to optimal levels. Risk factor attribution uses comparative risk assessment methodology, and a single death may be partially attributed to multiple risk factors.
Across the 48 countries in Sub-Saharan Africa tracked in this dataset, alcohol use accounts for an average of 0.2% of total deaths. The regional average of 0.2% falls below the global average of 0.4%, suggesting that Sub-Saharan Africa has a comparatively lower burden of alcohol use mortality than the world overall. In Sub-Saharan Africa, alcohol use mortality is comparatively low relative to other regions, though this may partly reflect younger population age structures and competing causes of death from infectious diseases.
Sub-Saharan Africa faces the world's most acute health challenges, with the youngest population of any region, the highest burden of infectious diseases, and health systems constrained by limited financing and workforce shortages. Within Sub-Saharan Africa, significant variation exists. Mauritius records the highest share at 0.7% of total deaths, while Sudan has the lowest at 0.03%. This 0.6 percentage-point spread reflects differences in exposure, health system capacity, demographic structure, and risk factor prevalence across the region. Country-level pages provide detailed mortality breakdowns, time trends, and comparisons for each nation.
The WHO's SAFER initiative outlines five high-impact strategies: strengthening restrictions on alcohol availability, advancing and enforcing drink-driving countermeasures, facilitating access to screening and brief interventions, enforcing bans on alcohol advertising and promotion, and raising prices through taxation. Minimum unit pricing, implemented in Scotland and parts of Canada, has demonstrated reductions in alcohol-related hospitalisations and deaths. Treatment for alcohol use disorder includes pharmacotherapy (naltrexone, acamprosate, disulfiram) alongside psychosocial interventions such as cognitive behavioural therapy and mutual support groups.
The mortality estimates presented on this page are derived from the Global Burden of Disease (GBD) study, produced by the Institute for Health Metrics and Evaluation (IHME). The GBD synthesizes data from vital registration systems, verbal autopsies, cancer registries, and surveillance networks across more than 200 countries and territories. Death rates are expressed per 100,000 population and are age-standardized, which adjusts for differences in age structure between populations so that comparisons across countries and over time reflect genuine differences in mortality risk rather than demographic composition.
The dataset typically covers the period from 1990 to 2023, although availability varies by country and cause. When interpreting the figures for alcohol use in Sub-Saharan Africa, note that higher age-standardized rates indicate a greater mortality burden independent of whether a country's population is older or younger. Trends over time reveal whether public health interventions, economic development, and health system improvements have reduced or increased the toll of this condition in the region.
Risk factor attribution in the GBD framework uses counterfactual analysis and population attributable fractions (PAFs). A PAF estimates the proportion of deaths that would not have occurred if exposure to a given risk factor had been at its theoretical minimum level. Because multiple risk factors can contribute to a single death, attributable fractions across all risk factors may sum to more than 100%. The figures for alcohol use in Sub-Saharan Africa reflect the estimated mortality burden that could be averted through complete elimination of this risk exposure.